Prof. Dr. Daniel Boll

The structured assessment of disease and subsequent quantification of relevant lesions leads to an effective and reproducible therapy response evaluation.

Related Resources

Related Resources

14th Annual AACI CRI Meeting

07/12 to 07/14/2022 CHICAGO, USA

A network for research leaders to develop and share best practices for the efficient operation of clinical trials offices at AACI cancer centers

Two computer screens showing the mint Lesion™user interface: a comparison of scans and an evaluation as a diagram

Scientifically proven benefits of mint Lesion™ in clinical routine

In contrast to clinical trials, unstructured free-text reporting is still common in the clinical routine. Such reports often lack content and clarity,…

Oncologic Imaging Course 2022

OIC 2022 – Oncologic Imaging Course

06/30 to 07/02/2022 Dubrovnik, Croatia

Oncologic imaging: Adding value while adapting to changing times.